Your browser doesn't support javascript.
loading
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Neelapu, Sattva S; Dickinson, Michael; Munoz, Javier; Ulrickson, Matthew L; Thieblemont, Catherine; Oluwole, Olalekan O; Herrera, Alex F; Ujjani, Chaitra S; Lin, Yi; Riedell, Peter A; Kekre, Natasha; de Vos, Sven; Lui, Christine; Milletti, Francesca; Dong, Jinghui; Xu, Hairong; Chavez, Julio C.
  • Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sneelapu@mdanderson.org.
  • Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Victoria, Australia.
  • Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Ulrickson ML; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Thieblemont C; Université de Paris, AP-HP, Hôpital Saint-Louis, Hemato-oncology, DMU HI, Paris, France.
  • Oluwole OO; Research Unit NF-kappaB, Différenciation et Cancer, Paris, France.
  • Herrera AF; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Ujjani CS; City of Hope National Medical Center, Duarte, CA, USA.
  • Lin Y; Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Riedell PA; Mayo Clinic, Rochester, MN, USA.
  • Kekre N; University of Chicago Medicine, Chicago, IL, USA.
  • de Vos S; Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Lui C; David Geffen School of Medicine at UCLA, Santa Monica, CA, USA.
  • Milletti F; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Dong J; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Xu H; Kite, a Gilead Company, Santa Monica, CA, USA.
  • Chavez JC; Kite, a Gilead Company, Santa Monica, CA, USA.
Nat Med ; 28(4): 735-742, 2022 04.
Article en En | MEDLINE | ID: mdl-35314842

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article